These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8673098)

  • 1. Menkes disease mutations and response to early copper histidine treatment.
    Kaler SG
    Nat Genet; 1996 May; 13(1):21-2. PubMed ID: 8673098
    [No Abstract]   [Full Text] [Related]  

  • 2. In utero copper treatment for Menkes disease associated with a severe ATP7A mutation.
    Haddad MR; Macri CJ; Holmes CS; Goldstein DS; Jacobson BE; Centeno JA; Popek EJ; Gahl WA; Kaler SG
    Mol Genet Metab; 2012 Sep; 107(1-2):222-8. PubMed ID: 22695177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A copper treatable Menkes disease mutation associated with defective trafficking of a functional Menkes copper ATPase.
    Kim BE; Smith K; Petris MJ
    J Med Genet; 2003 Apr; 40(4):290-5. PubMed ID: 12676902
    [No Abstract]   [Full Text] [Related]  

  • 4. A Truncating De Novo Point Mutation in a Young Infant with Severe Menkes Disease.
    Lin YJ; Ho CS; Hsu CH; Lin JL; Chuang CK; Tsai JD; Chiu NC; Lin HY; Lin SP
    Pediatr Neonatol; 2017 Feb; 58(1):89-92. PubMed ID: 25771438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menkes disease: importance of diagnosis with molecular analysis in the neonatal period.
    Costa LS; Pegler SP; Lellis RF; Krebs VL; Robertson S; Morgan T; Honjo RS; Bertola DR; Kim CA
    Rev Assoc Med Bras (1992); 2015; 61(5):407-10. PubMed ID: 26603002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The T1048I mutation in ATP7A gene causes an unusual Menkes disease presentation.
    León-García G; Santana A; Villegas-Sepúlveda N; Pérez-González C; Henrríquez-Esquíroz JM; de León-García C; Wong C; Baeza I
    BMC Pediatr; 2012 Sep; 12():150. PubMed ID: 22992316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mutations and clinical outcomes of copper-histidine therapy in Menkes disease patients.
    Kim JH; Lee BH; Kim YM; Choi JH; Kim GH; Cheon CK; Yoo HW
    Metab Brain Dis; 2015 Feb; 30(1):75-81. PubMed ID: 24919650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful early copper therapy in Menkes disease associated with a mutant transcript containing a small In-frame deletion.
    Kaler SG; Das S; Levinson B; Goldstein DS; Holmes CS; Patronas NJ; Packman S; Gahl WA
    Biochem Mol Med; 1996 Feb; 57(1):37-46. PubMed ID: 8812725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical manifestations of Menkes disease vary according to patient's genotype and the initiation time of treatment with copper-histidine injections].
    Yagi M; Kusunoki N; Lee T; Awano H; Kodama H; Takeshima Y; Iijima K
    No To Hattatsu; 2014 May; 46(3):227-8. PubMed ID: 24902345
    [No Abstract]   [Full Text] [Related]  

  • 10. Defective copper-induced trafficking and localization of the Menkes protein in patients with mild and copper-treated classical Menkes disease.
    Ambrosini L; Mercer JF
    Hum Mol Genet; 1999 Aug; 8(8):1547-55. PubMed ID: 10401004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper transport and its alterations in Menkes and Wilson diseases.
    DiDonato M; Sarkar B
    Biochim Biophys Acta; 1997 Feb; 1360(1):3-16. PubMed ID: 9061035
    [No Abstract]   [Full Text] [Related]  

  • 12. Prenatal diagnosis of Menkes disease.
    Kaler SG; Tümer Z
    Prenat Diagn; 1998 Mar; 18(3):287-9. PubMed ID: 9556046
    [No Abstract]   [Full Text] [Related]  

  • 13. Disturbed copper transport in humans. Part 1: mutations of the ATP7A gene lead to Menkes disease and occipital horn syndrome.
    Seidel J; Møller LB; Mentzel HJ; Kauf E; Vogt S; Patzer S; Wollina U; Zintl F; Horn N
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL141-8. PubMed ID: 11936860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Menkes' disease and brain dysfunction].
    Aoki T; Yamaguchi Y; Omura I; Watanabe A; Shimizu N
    No To Shinkei; 2001 May; 53(5):427-35. PubMed ID: 11424353
    [No Abstract]   [Full Text] [Related]  

  • 15. Menkes disease: recent advances and new aspects.
    Tümer Z; Horn N
    J Med Genet; 1997 Apr; 34(4):265-74. PubMed ID: 9138147
    [No Abstract]   [Full Text] [Related]  

  • 16. A green light glows on copper disorders research.
    Rinaldi A
    Trends Biochem Sci; 2001 Feb; 26(2):92. PubMed ID: 11166565
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of the exon structure of the Menkes disease gene using vectorette PCR.
    Tümer Z; Vural B; Tønnesen T; Chelly J; Monaco AP; Horn N
    Genomics; 1995 Apr; 26(3):437-42. PubMed ID: 7607665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of the promoter region in the Atp7a gene of the mottled dappled mouse.
    Levinson B; Packman S; Gitschier J
    Nat Genet; 1997 Jul; 16(3):224-5. PubMed ID: 9207785
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of three novel mutations in the MNK gene in three unrelated Japanese patients with classical Menkes disease.
    Ogawa A; Yamamoto S; Takayanagi M; Kogo T; Kanazawa M; Kohno Y
    J Hum Genet; 1999; 44(3):206-9. PubMed ID: 10319589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-onset treatment in Menkes disease: is there a correlation between genotype and response to therapy?
    Olivares JL; Bueno I; Gallati S; Ramos FJ
    Clin Genet; 2006 Apr; 69(4):363-6. PubMed ID: 16630173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.